Header cover image

Spanish (IBEX) Pharma Industry Analysis

UpdatedMar 26, 2024
DataAggregated Company Financials
Companies5
  • 7D2.6%
  • 3M16.3%
  • 1Y39.7%
  • YTDn/a

The Pharma industry is up 2.7% in the last week, with Laboratorios Farmaceuticos Rovi up 2.8%. In the last 12 months, the industry was up 39%. Looking forward, earnings are forecast to grow by 20% annually.

Industry Valuation and Performance

Has the Spanish Pharma Industry valuation changed over the past few years?

DateMarket CapRevenueEarningsPEAbsolute PEPS
Tue, 26 Mar 2024€7.0b€2.6b€223.6m20.9x31.5x2.7x
Thu, 22 Feb 2024€6.7b€2.6b€250.4m15.5x26.7x2.6x
Sat, 20 Jan 2024€6.3b€2.6b€296.4m16.3x21.3x2.4x
Mon, 18 Dec 2023€6.0b€2.6b€296.4m15.5x20.3x2.3x
Wed, 15 Nov 2023€5.6b€2.5b€305.3m14.9x18.2x2.2x
Fri, 13 Oct 2023€6.0b€2.5b€274.5m15.6x22x2.4x
Sun, 10 Sep 2023€5.9b€2.5b€274.5m14.8x21.6x2.4x
Tue, 08 Aug 2023€5.5b€2.5b€274.5m13.2x20x2.2x
Thu, 06 Jul 2023€4.8b€2.4b€284.3m11.3x16.9x2x
Sat, 03 Jun 2023€5.0b€2.4b€284.3m11.5x17.7x2.1x
Mon, 01 May 2023€5.0b€2.4b€301.6m17.8x16.7x2.1x
Wed, 29 Mar 2023€4.8b€2.4b€301.6m17.1x15.8x2x
Fri, 24 Feb 2023€5.3b€2.4b€294.7m31.6x17.9x2.2x
Sun, 22 Jan 2023€4.9b€2.3b€275.8m28.7x17.7x2.1x
Tue, 20 Dec 2022€4.8b€2.3b€275.8m28.1x17.5x2.1x
Thu, 17 Nov 2022€5.0b€2.3b€303.6m27x16.5x2.2x
Sat, 15 Oct 2022€5.4b€2.3b€306.3m22x17.7x2.3x
Mon, 12 Sep 2022€5.6b€2.3b€306.3m26.1x18.3x2.4x
Wed, 10 Aug 2022€6.0b€2.3b€306.3m29.2x19.7x2.6x
Fri, 08 Jul 2022€6.7b€2.3b€225.4m18.1x29.7x3x
Sun, 05 Jun 2022€6.7b€2.2b€220.3m18.5x30.4x3x
Tue, 03 May 2022€7.0b€2.2b€200.5m22.2x35x3.3x
Thu, 31 Mar 2022€7.2b€2.1b€200.5m24.8x36.1x3.4x
Sat, 26 Feb 2022€7.3b€2.1b€158.5m35.3x46.1x3.5x
Mon, 24 Jan 2022€6.7b€2.0b€177.1m31.2x38x3.3x
Wed, 22 Dec 2021€7.1b€2.0b€177.1m34.9x40.2x3.5x
Fri, 19 Nov 2021€6.6b€2.0b€157.7m40.4x41.7x3.3x
Sun, 17 Oct 2021€6.8b€2.0b€151.3m38.3x45.1x3.5x
Tue, 14 Sep 2021€7.1b€2.0b€151.3m39.2x46.8x3.6x
Thu, 12 Aug 2021€7.3b€2.0b€151.3m42x48.3x3.7x
Mon, 07 Jun 2021€7.1b€1.9b€205.9m44.8x34.3x3.8x
Price to Earnings Ratio

31x


Total Market Cap: €6.4bTotal Earnings: €205.9mTotal Revenue: €1.9bTotal Market Cap vs Earnings and Revenue0%0%0%
Spanish Pharma Industry Price to Earnings3Y Average 27.8x202220232024
Current Industry PE
  • Investors are optimistic on the Spanish Pharmaceuticals industry, and appear confident in long term growth rates.
  • The industry is trading at a PE ratio of 31.3x which is higher than its 3-year average PE of 27.8x.
  • The industry is trading close to its 3-year average PS ratio of 2.8x.
Past Earnings Growth
  • The earnings for companies in the Pharmaceuticals industry have grown 2.8% per year over the last three years.
  • Revenues for these companies have grown 11% per year.
  • This means that more sales are being generated by these companies overall, and subsequently their profits are increasing too.

Industry Comparison

How does Spanish Pharma compare with similar industries?

ES Market2.85%
Healthcare4.43%
Pharma2.59%
Pharma2.59%
Industry PEThere are no additional sub-industries under this industry.
Forecasted GrowthThere are no additional sub-industries under this industry.

Top Stock Gainers and Losers

Which companies have driven the market over the last 7 days?

CompanyLast Price7D1YValuation
ROVI Laboratorios Farmaceuticos Rovi€80.402.2%
+€88.1m
105.6%PE24.5x
FAE Faes Farma€3.198.1%
+€74.7m
0.8%PE10.8x
ALM Almirall€8.051.1%
+€17.8m
-7.2%PS1.9x
Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.